Bin Su, PhD
Associate Professor, Chemistryb.email@example.com 216.687.9219 (o) 216.687.9298 (f)
Member, Molecular Oncology Program
My research group focuses on synthetic medicinal chemistry to lead optimize the structure of anti-cancer agents. Currently, we develop dual tubulin and HSP27 inhibitors based on COX-2 inhibitor Nimesulide as a lead compound. In addition, we collaborate with Drs. Monica Montano and Bingcheng Wang to optimize HMBA and EphA2 agonist as anti-cancer agents.